AVA Genomics Consultancy ApS: Financial statements 2022
CVR: 37493678
Source: annual report 2022, Danish Business Authority
01/07/2021 – 30/06/2022
AVA Genomics Consultancy ApS (CVR 37493678) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK -18,813 and a net result of DKK -19,897 compared with DKK 25,322 the year before. Equity in the 2022 report amounted to DKK 20,103. The solvency ratio was 25.8%.
- Gross Profit
- DKK -18,813
- Profit/Loss
- DKK -19,897
- Equity
- DKK 20,103
- Total Assets
- DKK 77,792
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | - | -19 t. | -20 t. | 20 t. | - |
| 2021 | - | 34 t. | 25 t. | 35 t. | 1 |
| 2020 | - | -117 | -135 | 10 t. | 0 |
| 2019 | - | 18 t. | 10 t. | 10 t. | 0 |
| 2018 | - | -2 t. | -2 t. | -114 | 0 |
Official annual report
Keep an eye on AVA Genomics Consultancy ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringAbout AVA Genomics Consultancy ApS
AVA Genomics Consultancy ApS is a Danish company of the type Anpartsselskab based in Randers SV, founded in 2016. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named AVA Genomics and Breeding Consultancy IVS. The management consists of Haja Najeemudin Kadarmideen. The company is owned by Haja Najeemudin Kadarmideen. The company has 1 employee (2026). In 2026, the company reported a gross profit of DKK 14,728 and a net result of DKK -4,294 compared with DKK -18,733 the year before. Equity in the 2026 report amounted to DKK 90,595.